Director David S. Cunningham to retire from ImmuCell Board after 2023 Annual Meeting

IMMUCELL CORP /DE/

David S. Cunningham notified retirement effective after June 15, 2023 Annual Meeting.
Retirement not due to any disagreement with the company on operations, policies, or practices.
No replacement for the departing director has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David S. Cunningham

Director

ICCC · IMMUCELL CORP /DE/

Effective: 2023-06-15
Filed: February 1, 2023, 6:59 PM ET

On January 24, 2023, David S. Cunningham notified ImmuCell Corporation (the “Company”) of his intention to retire from the Board of Directors (the “Board”) effective immediately following the Company’s 2023 Annual Meeting to be held on June 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David S. Cunningham departed as Director at IMMUCELL CORP /DE/.

Action: retire
Role: Director

Exact text from the filing

On January 24, 2023, David S. Cunningham notified ImmuCell Corporation (the “Company”) of his intention to retire from the Board of Directors (the “Board”) effective immediately following the Company’s 2023 Annual Meeting to be held on June 15, 2023.

View on SEC.gov

IMMUCELL CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001213900-23-006754

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.